What should you know about new GLP-1 receptor agonists?

These medicines mimic signals released after eating. They can slow stomach emptying, increase fullness, and influence insulin and glucagon activity when blood glucose changes. The exact medicine, dose, and approved use differ, so treatment must be matched to your health history.

They may be prescribed for type 2 diabetes, weight management, or another specific indication. They are not a substitute for assessing unexplained symptoms, reviewing other medicines, or addressing nutrition, activity, sleep, and emotional factors.

Use the prescribed dose and schedule; do not share pens or change the dose without clinical advice. Eat slowly, choose fluids, and tell your clinician about vomiting, diarrhoea, severe constipation, gallbladder problems, kidney disease, pancreatitis, pregnancy, or planned surgery.

Nausea, reduced appetite, vomiting, diarrhoea, and constipation are possible, particularly after starting or increasing treatment. A clinician may adjust the dose or review whether this medicine remains appropriate. More detail is available under GLP-1 Receptor Agonist and Weight Loss Injections.

Get urgent medical advice for severe or persistent abdominal pain, repeated vomiting, inability to keep fluids down, faintness, or signs of an allergic reaction such as facial swelling or breathing difficulty. Seek prompt help for symptoms of very low or high blood glucose when the medicine is used with other glucose-lowering treatments.

Ask what outcome is being treated, how dose changes will work, which symptoms require a call, how your other medicines may interact, and what monitoring or follow-up appointments you need.